Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000151772 | SCV000200190 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | Pro3647Pro in exon 78 of RYR2: This variant is not expected to have clinical sig nificance because it does not alter an amino acid residue and is not located wit hin the splice consensus sequence. It has been identified in 0.1% (4/6562) of Eu ropean American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS). Pro3647Pro in exon 78 of RYR2 (al lele frequency = 0.1%, 4/6562) ** |
Labcorp Genetics |
RCV001096209 | SCV000285689 | likely benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000621644 | SCV000735863 | likely benign | Cardiovascular phenotype | 2017-05-15 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
CHEO Genetics Diagnostic Laboratory, |
RCV000769804 | SCV000901230 | likely benign | Cardiomyopathy | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV000769804 | SCV000903378 | benign | Cardiomyopathy | 2018-06-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000229147 | SCV001147776 | likely benign | not provided | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001096208 | SCV001252405 | uncertain significance | Arrhythmogenic right ventricular dysplasia 2 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases did not allow this variant to be ruled in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Illumina Laboratory Services, |
RCV001096209 | SCV001252406 | benign | Catecholaminergic polymorphic ventricular tachycardia 1 | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. |
ARUP Laboratories, |
RCV000229147 | SCV001474288 | likely benign | not provided | 2020-02-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000229147 | SCV001916402 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000151772 | SCV002500686 | benign | not specified | 2022-03-28 | criteria provided, single submitter | clinical testing | |
All of Us Research Program, |
RCV003998227 | SCV004816030 | benign | Catecholaminergic polymorphic ventricular tachycardia | 2024-02-05 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV000229147 | SCV001740974 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000151772 | SCV001920362 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000229147 | SCV001932711 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000151772 | SCV001953953 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000229147 | SCV001972695 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004544362 | SCV004773634 | likely benign | RYR2-related disorder | 2023-04-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |